Pre-Clinical Trial Application (CTA) Consultation Meeting

The pre-CTA consultation meeting provides an opportunity for the sponsor to present relevant data, discuss concerns and resolve issues regarding drug development. It also gives Health Canada an opportunity to provide guidance on the acceptability of the proposed trial(s).

Publisher
Health Canada
Resources
2
Catalogue metadata updated
2022-06-07

Data overview

Formats
HTML
File languages
English, French

Official sources and licences

Resources

Related open data